Compass Oncology

What Compass Oncology does

Compass Oncology is a private, multi-site community oncology practice headquartered in the Portland-Vancouver metropolitan area, operating across five clinical locations in Oregon and Southwest Washington (East Cancer Center in Happy Valley, Rose Quarter, West Cancer Center, Vancouver Cancer Center, and the announced Northwest Center). The practice delivers comprehensive cancer care spanning medical oncology (chemotherapy, immunotherapy, targeted therapy, hormone therapy), radiation oncology (including stereotactic radiosurgery, stereotactic body radiation therapy, and high dose rate brachytherapy), surgical oncology (breast, gynecologic, and hepatopancreatic), and diagnostic services (PET-CT imaging, genetic and genomic testing). It runs more than 70 active clinical trials at any given time and is affiliated with The US Oncology Network, a national oncology platform that provides research, procurement, and operational infrastructure.

The clinical offering is complemented by in-house pharmacy, oncology social services, survivorship programs, and supportive-care devices (Paxman scalp cooling for breast cancer patients, SpaceOAR hydrogel for prostate radiation). Compounding services are billed primarily through private and public health insurance, with Patient Benefits Representatives supporting coverage navigation; the practice holds ACR, NCQA, and APEx accreditations plus HIPAA compliance. Customer acquisition runs through physician referrals, self-referrals, second opinions, and community outreach channels (CompassTalks, awareness-month campaigns, lung force fundraisers with the American Lung Association).

The practice is structured as a private oncology group operating under the US Oncology Network umbrella; no external venture or private-equity funding is disclosed. Strategic positioning emphasizes breadth of service under one regional brand, sustained capital investment in physical infrastructure (40,000 sq ft East Cancer Center opened 2024), and depth of clinical-trial participation as a differentiator against adjacent community oncology competitors and academic referral centers.

Name

Compass Oncology

Legal name

Compass Oncology

Website

https://compassoncology.com

Company type

Private

Founded year

1999

Operating status

Operating

Headcount range

251–500 employees

Short description

Compass Oncology is a private, multi-site community oncology practice serving the Portland-Vancouver metro with medical, radiation, and surgical oncology, diagnostics, supportive care, and over 70 active clinical trials as a US Oncology Network affiliate.

Ownership category

akta.pro rank

Product category

Oncology Services

NAICS

Other Ambulatory Health Care Services (6219)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro industry

PRIMARYHLAKAFAB

Medical Oncology

Healthcare & Life Sciences/Specialist Medical Practice/Hematology & Oncology

SECONDARYHLAKAFAC

Radiation Oncology

Healthcare & Life Sciences/Specialist Medical Practice/Hematology & Oncology

SECONDARYHLAKAFAG

Surgical Oncology

Healthcare & Life Sciences/Specialist Medical Practice/Hematology & Oncology

Keywords

• Cancer treatment services
• Radiation oncology care
• Clinical cancer trials
• Oncology diagnostic imaging
• Surgical oncology services

Headquarters

HQ city

Vancouver

HQ country

United States

HQ region

North America

Offices6 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Supply Chain, Operations, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

1. Medical Oncology Services: Revenue generated from chemotherapy, immunotherapy, targeted therapy, and hormone therapy treatments for cancer patients
2. Radiation Oncology Services: Revenue from radiation therapy treatments including SRS, SBRT, HDR brachytherapy, and traditional radiation therapy
3. Diagnostic Services: Revenue from imaging services (PET-CT scans), genetic testing, genomic testing, and laboratory diagnostics
4. Surgical Oncology: Revenue from breast surgical oncology, gynecologic surgical oncology, and liver/pancreatic surgical procedures
5. Clinical Trials: Research trials sponsored by Compass Oncology, with over 70 active trials at any given time
6. Pharmacy Services: Oncology pharmacy providing medications to patients

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

Core offering

Compass Oncology is a comprehensive cancer treatment practice that delivers medical oncology, radiation oncology, surgical oncology, and supportive care services to patients in the Portland-Vancouver metropolitan area. Treatment offerings include chemotherapy, immunotherapy, targeted therapy, hormone therapy, advanced radiation techniques (SRS, SBRT, HDR brachytherapy), and surgical procedures, supported by diagnostic imaging (PET-CT), genetic and genomic testing, and a research program with more than 70 active clinical trials at any given time.

Product overview

Compass Oncology is a comprehensive cancer care provider offering a unified suite of treatment services across multiple cancer types. The core clinical services include chemotherapy, radiation therapy, surgery, immunotherapy, targeted therapy, and hormone therapy. These treatments are supported by advanced diagnostic services including PET-CT imaging, genetic testing, and genomic testing for personalized treatment planning. The practice provides access to clinical trials and research programs, along with supportive care services including pharmacy, oncology social services, and survivorship programs. Specialized radiation techniques include High Dose Rate Brachytherapy, Stereotactic Body Radiation Therapy (SBRT), and Stereotactic Radiosurgery (SRS). Patient support is enhanced through devices like the Paxman Scalp Cooling System and SpaceOAR Hydrogel.

Differentiator

Problem solved

Functional benefit

Products and services

• Chemotherapy

Quantifiable outcome

• Patients requiring less dosage and fewer delays in chemotherapy treatments when participating in resistance training during treatment
• +2 more outcomes

Named customers2 records

Segments4 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Partnerships

Seven partnerships are on record, tiered core and minor.

• The US Oncology NetworkcoreStrategic or Co-development PartnerCompass Oncology is part of The US Oncology Network, providing access to shared resources, research capabilities, and best practices in cancer care delivery across the network.
• GRAIL (Circulating Cell-free Genome Atlas Study)coreStrategic or Co-development PartnerParticipation in the CCGA (Circulating Cell-free Genome Atlas) clinical study for early cancer detection using next-generation sequencing-based assays. The study involves analyzing cell-free nucleic acids from blood components and tumor tissue.
• Gamma Knife Center of OregoncoreStrategic or Co-development PartnerCollaboration for stereotactic radiosurgery treatments. Compass radiation oncologists perform SRS at this center in addition to Vancouver and Rose Quarter locations.
• Science Translational Medicine (Research Collaboration)minorStrategic or Co-development PartnerDr. Ravi Chandra, Compass Radiation Oncologist, co-authored a research article published in Science Translational Medicine about enhancement of drug delivery to tumors through vascular bursting induced by radiation therapy.
• American Lung AssociationminorGTM or Marketing PartnerPartnership for Lung Cancer Awareness Month activities including Lung Force Walk/Run fundraising events and awareness campaigns.
• The Conversation ProjectminorOthersEnd-of-life care planning resource recommended by Compass Oncology's social workers to help patients start conversations about advance care planning.
• National Healthcare Decisions DayminorOthersHealthcare initiative supported by Compass Oncology to promote advance care planning awareness among patients and families.

Scale indicators4 records

Recent moves7 records

Expansion highlights5 records

Broad incumbents

• OHSU Knight Cancer Institute: NCI-designated academic cancer center based in Portland, Oregon. Directly competes with Compass for oncology patients in the same metro area and offers advanced research and clinical trial access, though as an academic institution with a different operating model.
• City of Hope: Major NCI-designated comprehensive cancer center that acquired Cancer Treatment Centers of America. Operates a national footprint with multi-modality cancer care and clinical research, comparable in service breadth though anchored in academic specialty care.
• Sarah Cannon (HCA Cancer Institute): HCA Healthcare's cancer institute running one of the largest community-based clinical trial networks in the US. Comparable in clinical trial scale and community oncology delivery model, though embedded within a larger hospital system.
• Fred Hutchinson Cancer Center: NCI-designated comprehensive cancer center in Seattle offering multi-modality oncology care and clinical research. Comparable in clinical trial leadership and academic-grade cancer services, though operating in a different regional market.

Direct peers

• Texas Oncology: One of the largest community-based oncology practices in the US, also part of The US Oncology Network. Operates a comparable multi-modality model across multiple Texas sites, making it the closest structural peer to Compass Oncology.
• Rocky Mountain Cancer Centers: Community oncology practice providing medical, radiation, and hematology services across the Rocky Mountain region, also affiliated with The US Oncology Network. Directly comparable in scope, service mix, and network affiliation to Compass.
• Northwest Medical Specialties: Pacific Northwest community oncology and hematology practice providing chemotherapy, immunotherapy, and clinical trial access. Directly comparable service offering and regional patient base to Compass.
• Tennessee Oncology: Large community-based oncology practice offering multi-modality cancer care and clinical trials, affiliated with OneOncology. Directly comparable service model and community oncology positioning to Compass Oncology.

Regional players

• Willamette Valley Cancer Institute: Community oncology practice serving Oregon and the broader Pacific Northwest, offering medical oncology, radiation oncology, and clinical trials. Operates in a partially overlapping geography with Compass.

Others

• OneOncology: Network platform partnering with independent community oncology practices (including Tennessee Oncology and others). Comparable network-affiliated operating model to Compass's affiliation with The US Oncology Network.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/compassoncology
• LinkedInlinkedin.com/company/compass-oncology

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Compass Oncology